North Fourth Asset Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
PVMCV
CPV
FCM
CC
DCM
North Fourth Asset Management's CDLX Position: Q4 2018 in Review
North Fourth Asset Management sold out of Cardlytics (CDLX) in Q4 2018, closing a stake of 10,441 shares — an estimated $2.61M sold.
North Fourth Asset Management first reported a position in CDLX in Q3 2018 and held it in 1 quarter. The position peaked at $2.61M in Q3 2018. 61 funds tracked by Wall St. Rank hold CDLX as of Q4 2018.
- North Fourth Asset Management reported no remaining Cardlytics position as of Q4 2018 after selling out during the quarter.
- North Fourth Asset Management sold 10,441 Cardlytics shares in Q4 2018, an estimated $2.61M.
- North Fourth Asset Management first reported a position in Cardlytics in Q3 2018 and held it in 1 quarter.
- North Fourth Asset Management's Cardlytics position peaked at $2.61M in Q3 2018.
- 61 funds tracked by Wall St. Rank held Cardlytics as of Q4 2018.
Based on North Fourth Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.